Todd Neale

New York

Senior Medical Journalist and Associate News Editor at TCTMD

Senior Medical Journalist/Associate News Editor for TCTMD

Featured in: Favicon

tctmd.com

go.com

medpagetoday.com Favicon

newsbreak.com Favicon

climatedepot.com Favicon

abcnews.go.com

Articles

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

5 days ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 The intervention, tested out in Ghana, is unique as it relies on basic mobile phones, not smartphones. HELSINKI, Finland—In Ghana, survivors of a recent stroke who had hypertension experienced significant improvements in blood pressure control with a simple, mobile-health (mHealth) intervention led by nurses, according to the results of the PINGS-2 trial.
High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants

1 week ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 The findings highlight the need to both ensure adherence to anticoagulation and control other risk factors. HELSINKI, Finland—Patients with atrial fibrillation (AF) who have had an ischemic stroke continue to have a high risk of recurrent stroke even when they’re treated with oral anticoagulation, a systematic review and meta-analysis shows.
Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain

1 week ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 Pulling back on the level of monitoring could improve nursing workflows and reduce resource use. HELSINKI, Finland—It may be possible to safely cut back on the level of monitoring performed in select patients with acute ischemic stroke treated with IV thrombolysis, results of the OPTIMISTmain trial suggest.
ASSET-IT: Tirofiban Boosts Outcomes After IV Thrombolysis for Acute Stroke

1 week ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 Citing a low hemorrhage rate and other issues, one expert says the results should be replicated before changing practice. HELSINKI, Finland—Adding IV tirofiban improves functional outcomes among patients undergoing systemic thrombolysis for acute ischemic stroke within 4.5 hours of symptom onset, results from the randomized ASSET-IT trial indicate.
Don’t Forget to Floss! Better Oral Hygiene May Help Stave Off Stroke

2 weeks ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 Oral hygiene is often neglected when it comes to stroke, but it’s low-hanging fruit than can aid in primary prevention. HELSINKI, Finland—People who report taking better care of their teeth, particularly with flossing, appear to have a lower risk of stroke over the long term, according to an analysis of the Atherosclerosis Risk in Communities (ARIC) study.
IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

2 weeks ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 Findings from the Chinese randomized trial support what most centers in the US are already doing, one expert says. HELSINKI, Finland—Patients with acute ischemic stroke caused by a large-vessel occlusion (LVO) who are undergoing endovascular thrombectomy fare better when intravenous tenecteplase (TNK) is administered beforehand, according to results from the randomized BRIDGE-TNK trial.
Even Small Amounts of Exercise May Help Older Women Avoid Stroke

2 weeks ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 The findings from the Women’s Health Initiative are in line with recent guidelines for the primary prevention of stroke. HELSINKI, Finland—The more recreational activity postmenopausal women can do at any level, the lower their likelihood of stroke, data from the Women’s Health Initiative indicate. Each standard deviation (SD) increase in total activity was associated with a 10% lower relative risk of stroke over several years of follow-up.
Finerenone May Cut Early Readmissions in HF Patients

2 weeks ago | tctmd.com | Todd Neale

News Conference News ESC Heart Failure 2025 These exploratory results from the FINEARTS-HF trial require confirmation in dedicated trials. REDEFINE-HF is underway.
TITRATE-HF: Use of GDMT for HF Is Getting Better but Still Not Ideal

2 weeks ago | tctmd.com | Todd Neale

News Conference News ESC Heart Failure 2025 The observed treatment rates, which “absolutely can go higher,” wouldn’t be acceptable for serious cancers, Stephen Greene says.
No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

2 weeks ago | tctmd.com | Todd Neale

News Conference News ESC Heart Failure 2025 The “somewhat unexpected” finding is likely related to the profound impact on health status from the procedure itself. BELGRADE, Serbia—Dapagliflozin (Farxiga; AstraZeneca) does not further improve quality of life in older patients with aortic stenosis and a history of heart failure (HF) undergoing TAVI despite reducing the risk of all-cause mortality and worsening HF, a substudy of the DapaTAVI trial shows.